VELIZY-VILLACOUBLAY, France — November 13, 2019 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA) is holding a Life Sciences Day for analysts and investors, today, Wednesday, November 13th, 2019 starting at 09.00 am ET in New York. The event includes presentations by the senior executive management team. The sessions are being webcast live and will be available for replay by accessing https://investor.3ds.com/events/event-details/life-sciences-day.
Bernard Charlès, Dassault Systèmes’ Vice Chairman and Chief Executive Officer commented:
“Health is now core (with Life Sciences our second largest industry) we have a simple dream: help health innovators power smarter therapeutics for healthier people. In the age of precision medicine and patient experiences, it is clear that the future of healthcare will be shaped by inclusive and multi-discipline platforms enabling virtual twin experiences for healthcare. We made virtual twins of cars and airplanes possible. We will do the same for the human body.
“The 3DEXPERIENCE platform combines modeling, simulation, data science, AI, and collaboration in the virtual world to achieve sustainable innovation in Life Sciences. Today, Dassault Systèmes brings a new, unified, end-to-end approach to research and discovery, development, clinical testing, manufacturing and commercialization of new therapies and health technologies.
“From a customer perspective the opportunity is significant – with a potential reach to 4,500 pharmaceutical and biotech companies and over 50,000 medical devices companies.”
Pascal Daloz, Dassault Systèmes’ Executive Vice President, CFO and Corporate Strategy Officer, commented:
“In June of 2018 we initiated our 2018-2023 plan to double our non-IFRS EPS, to a goal of about €6.00. From a revenue perspective, our key growth drivers include the 3DEXPERIENCE platform and industry solution experiences, our expanding global footprint bringing diversification and balance by industry and geography, and new usage opportunities with the Cloud. Complementing our key growth drivers, is the recent addition of Medidata Solutions following the completion of its acquisition on October 28th, 2019. Based upon our assessment of its growth opportunities between 2020 and 2023, we estimate that Medidata will contribute approximately €0.70 and, more importantly, will set in motion future growth potential beyond 2023.”